KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Intangibles (2016 - 2025)

Historic Intangibles for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $20.5 billion.

  • Bristol Myers Squibb's Intangibles fell 2410.25% to $20.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 billion, marking a year-over-year decrease of 2410.25%. This contributed to the annual value of $23.3 billion for FY2024, which is 1390.74% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Intangibles stood at $20.5 billion for Q3 2025, which was down 2410.25% from $21.4 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Intangibles peaked at $50.8 billion during Q1 2021, and registered a low of $20.5 billion during Q3 2025.
  • In the last 5 years, Bristol Myers Squibb's Intangibles had a median value of $32.8 billion in 2024 and averaged $33.5 billion.
  • In the last 5 years, Bristol Myers Squibb's Intangibles crashed by 241.0% in 2024 and then crashed by 3136.14% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Intangibles stood at $42.5 billion in 2021, then dropped by 15.68% to $35.9 billion in 2022, then dropped by 24.5% to $27.1 billion in 2023, then dropped by 13.91% to $23.3 billion in 2024, then dropped by 12.19% to $20.5 billion in 2025.
  • Its Intangibles stands at $20.5 billion for Q3 2025, versus $21.4 billion for Q2 2025 and $22.5 billion for Q1 2025.